cbdMD Announces Company's CEO Joins the Board of Directors

Company Overview - cbdMD, Inc. is a leading and highly trusted cannabidiol (CBD) brand, offering a comprehensive line of U.S. produced, THC-free CBD products, including NSF Certified for Sport® products and new Full Spectrum products [2] - The product range includes CBD tinctures, gummies, topicals, capsules, bath bombs, sleep aids, drink mixes, and pet products under the Paw CBD brand, as well as natural functional mushroom products under the ATRx brand [2] Leadership and Strategic Developments - T. Ronan Kennedy, the CEO and CFO of cbdMD, has been appointed to the Board of Directors, effective December 18, 2024, expanding the board to five members [7] - Under Kennedy's leadership, cbdMD has implemented a turnaround strategy that has resulted in substantial cost savings, improved profitability metrics, and established a foundation for future growth [1][8] - The company has made significant progress in optimizing its cost structure and enhancing operational fundamentals, positioning itself for long-term success as it enters 2025 with a stronger cash position and growth opportunities [8]